clarithromycin has been researched along with Angina at Rest in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ärnlöv, J; Bring, C; Carlsson, AC; Gluud, C; Hilden, J; Jakobsen, JC; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Larsson, A; Sajadieh, A; Winkel, P; Wuopio, J | 1 |
Berg, HF; Kluytmans, JA; Maraha, B; Peeters, MF; Quarles-van Ufford, M; Scheffer, GJ; Vandenbroucke-Grauls, CM | 1 |
Anttonen, O; Juvonen, J; Mattila, K; Melin, J; Nieminen, MS; Sinisalo, J; Valtonen, V; Vuorinen-Markkola, H | 1 |
3 trial(s) available for clarithromycin and Angina at Rest
Article | Year |
---|---|
Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
Topics: Aged; Angina, Unstable; Atherosclerosis; Cardiovascular Diseases; Cathepsin B; Cathepsins; Cerebrovascular Disorders; Clarithromycin; Coronary Disease; Denmark; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Lysosomes; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Registries; Risk Factors; Treatment Outcome | 2018 |
Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.
Topics: Aged; Angina, Unstable; Anti-Bacterial Agents; Atherosclerosis; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Bypass; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Surgical Wound Infection; Treatment Outcome | 2005 |
Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome.
Topics: Adolescent; Adult; Aged; Angina, Unstable; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Survival Rate; Syndrome; Time Factors | 2002 |